Drug intelligence / Profile preview

wild-type oncolytic adenovirus

Development stage
Preclinical
Lead developer
University of Minnesota
Modality
Oncolytic Viruses → Oncolytic Therapeutics, Gene Therapies
Administration
Intratumoral, Intravenous
01

Overview

Wild-type oncolytic adenovirus refers to a naturally occurring or minimally modified adenovirus (typically Serotype 5) that possesses innate oncolytic properties. Unlike engineered oncolytic viruses that are modified for tumor selectivity (e.g., through promoter control or gene deletions), the wild-type virus is universally replicative in permissive cells. In cancer research, it is frequently used as a positive control to benchmark the lytic efficiency and replication kinetics of novel, tumor-selective oncolytic vectors. It functions by infecting cells, replicating its genome, and inducing cell lysis, thereby releasing progeny virions to infect adjacent cells. Studies, such as those conducted at the University of Minnesota, have evaluated its interaction with chemotherapeutic agents like 5-fluorouracil (5FU) in pancreatic and esophageal cancer models.

Other names
wild-type adenovirusWT-Aduniversally replicative adenovirus
02

Targets

CXADR (Coxsackievirus and adenovirus receptor)Neuraminidase

Beyond the preview

Go deeper on wild-type oncolytic adenovirus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on wild-type oncolytic adenovirus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call